AstraZeneca's Lynparza helps prostate cancer patients live longer: study

AstraZeneca said on Wednesday its cancer drug, Lynparza, was successful in helping patients with metastatic prostate cancer and certain genetic mutations live longer without the disease worsening, compared with the standard of care.

from Reuters: Health News https://ift.tt/2OMsjEI